Recombinant Human PPY Protein，His

The study of PPY (Pancreatic Polypeptide Y), a vital neuropeptide involved in the regulation of appetite and energy homeostasis, has gained significant attention in recent years due to its potential therapeutic applications in obesity and metabolic disorders. PPY is primarily secreted by the pancreatic islets and plays a crucial role in signaling pathways that govern satiety and food intake. Abnormal levels of PPY have been linked to various conditions, including obesity, diabetes, and eating disorders, prompting researchers to explore the molecular mechanisms underlying its production and action. The recombinant production of PPY allows for detailed studies of its structure-function relationship and facilitates the development of pharmacological agents that can modulate its activity. Advances in expression systems, such as bacteria and yeast, have enabled the efficient synthesis and purification of functional PPY, providing valuable tools for investigating its interactions with receptors and other signaling molecules. Moreover, understanding the role of PPY in the central nervous system and its peripheral effects may uncover novel strategies for managing weight and improving metabolic health. As research progresses, the potential for PPY-based therapies continues to expand, making it a focal point in the pursuit of innovative solutions to combat obesity and related metabolic disorders.